Fkbp5 gene fragment containing 163g>c mutation, encoded protein fragment and application thereof
A gene and nucleic acid fragment technology, applied in the field of FKBP5 gene mutation, can solve the problems of lack of immunosuppressive drug binding ability and PPIase activity, and achieve the effect of increasing osteoclast ability, increasing phosphorylation level, and strong clinical guidance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Embodiment 1: the acquisition of human FKBP5 gene mutation site
[0047] A case of familial clustered Paget bone disease in the Chinese Han population was obtained from the Third People's Hospital of Jinan City, see the pedigree figure 1 , family members gave informed consent to this study. There were 3 patients in the family, namely Ⅱ3, Ⅱ6 and Ⅱ11. According to the imaging examination results of the skeletal system, serological examination results, clinical symptoms and signs, Paget's disease of bone can be clearly diagnosed. The peripheral blood whole blood of the patient and other family members was extracted, and the genomic DNA was extracted using the QIAGEN whole blood small amount DNA extraction kit for gene mutation detection and analysis.
[0048] 1. Sequencing analysis of Paget bone disease susceptibility genes
[0049] Primers were designed for known paget susceptibility genes, including SQSTM1, TNFRSF11A, TNFRSF11B, OPTN, VCP, CSF1, and DCSTAMP, and the e...
Embodiment 2
[0064] Embodiment 2: FKBP5 gene mutation verification
[0065] In order to verify the gene mutation in the family and confirm whether the mutation is an unreported SNP site in the Han population, the gene sequence of the exon 4 of the FKBP5 gene of all family members and 200 normal controls contains the mutation site Perform sequencing analysis.
[0066] 1. Fragment PCR containing mutation site 163G>C
[0067] Using the genomic DNA of all family members and 200 normal controls as templates, the gene fragment containing the FKBP5c.163G>C gene mutation site was amplified.
[0068] The amplification primer fragments are: upstream 5'-ATTAAACCAATGAACAGGAT-3' (SEQ ID NO.5); downstream 5'-CACAACTCAAAAAAAATACCC-3' (SEQ ID NO.6); product length: 446bp.
[0069] The PCR amplification system is as follows:
[0070] TaKaRa Ex Taq HS (5U / μL) 0.1μL
[0071] 10×Ex Taq buffer 2μL
[0072] dNTP mix (2.5mM each) 2μL
[0073] DNA 100ng
[0074] Primers (upstream and downstream primer mix,...
Embodiment 3
[0110] Example 3: Effect of FKBP5 gene mutation on NF-κB and Akt signaling pathways
[0111] 1. Construction of eukaryotic expression vectors expressing wild-type and mutant FKBP5 proteins
[0112] The pcDNA3.1 vector was purchased from Invitrogen (Carlsbad, CA, USA). By designing primers, a BamH I restriction site was introduced at the 5' end of the FKBP5 gene CDS sequence, and an EcoR I restriction site was introduced at the 3' end. The primer sequences are as follows: upstream 5'-GGATCCATGACTACTGATGAAGGTG-3'; downstream 5'-GAATTCTCATACGTGGCCCTCAGGTT-3'. Using the primers, the target fragment is amplified using the wild-type or mutant FKBP5 gene CDS sequence as a template. The PCR product was recovered and purified using a general-purpose DNA purification and recovery kit (Tiangen Biochemical Technology (Beijing) Co., Ltd.).
[0113] The purified PCR product was connected to the pMD18-T (Takara, Tokyo, Japan) connection vector, and the positive clones connected with the w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com